Ireland
--:--IST
Latest
Clinical Trials in France / NCT05915559
Active, not recruiting Not applicable

Outpatient Management of Tonsillectomy in Adults

NCT05915559 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2023-06-01
Last updated
2025-08-24

Condition(s) studied

TonsillectomyPainAmbulatory

Investigational drug(s) / intervention(s)

Tonsillectomydaily follow-up

Tonsillectomy: Tonsillectomy

daily follow-up: daily follow-up of clinical parameters (pain, feeding) and analgesia adapted to the pain

Study summary

Tonsillectomy is a frequent surgical procedure in the ENT specialty but it can be a source of postoperative pain that can be important. These pains complicate the intake of food and in particular the intake of analgesic drugs per os and require the prolongation of the hospitalization in order to continue an intravenous analgesia. The aim is to set up a protocol for ambulatory care of adult tonsillectomies. Then, it would allow an improvement of the postoperative quality of life for the patient, who prefers a quicker return home.The study aims to allow patients to come back home early after tonsillectomies with intravenous analgesia. Pain, feeding and quality of life will be evaluated regularly through an application called MAELA during a few days after surgery. They will also be evaluated by nurses coming via providers.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Indication for a tonsillectomy defined in the French recommendations * Age between 18 and 60 yo * Providing free and informed consent to participate * Having a smartphone able to process MAELA application * Affiliation to french social security

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHU Amiens Amiens France

More Centre Hospitalier Universitaire, Amiens trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05915559 on ClinicalTrials.gov ↗ ← All trials in France